Submitted on June 13, 2007
Revised on April 23, 2008
Accepted on July 31, 2008
Transketolase and CNPase I are specifically recognized by IgG autoantibodies in multiple sclerosis patients
Laura Lovato, Riccardo Cianti, Beatrice Gini, Silvia Marconi, Laura Bianchi, Alessandro Armini, Elena Anghileri, Francesca Locatelli, Francesco Paoletti, Diego Franciotta, Luca Bini, and Bruno Bonetti
Department of Neurological Sciences and Vision, University of Verona, Verona 37134
Corresponding Author: bruno.bonetti{at}univr.it
The presence of autoantibodies in multiple sclerosis (MuS) is well known, but their target antigens have not been clearly identified. In the present study, IgG autoreactivity to neural antigens of normal human white matter separated by bi-dimensional electrophoresis was assessed in serum and cerebro-spinal fluid (CSF) of 18 MuS and 20 control patients. Broad IgG autoreactivity was detected by 2D-immunoblotting in all cases to neural antigens, most of which have been identified by mass spectrometry. The comparative analysis of MuS and non-MuS reactive spots showed that a restricted number of neural protein isoforms was specifically recognized by MuS IgG. Almost all MuS patients had CSF IgG directed to isoforms of one of the oligodendroglial molecules transketolase (TK), cyclic nucleotide phosphodiesterase type I (CNPase I), collapsin response mediator protein 2 and tubulin beta4. Interestingly, 50% of MuS IgG recognized TK, which was mostly localized on oligodendrocytes in human white matter from normal and MS samples. IgG autoreactivity to cytoskeletal proteins (radixin, sirtuin 2 and actin interacting protein 1) was prevalent in secondary progressive MuS patients. Among the proteins recognized by serum IgG, almost all MuS patients specifically recognized a restricted number of neuronal/cytoskeletal proteins, while CNPase I was the oligodendroglial antigen most frequently recognized (44%) by MuS seric IgG. Our immunomic approach shed new light on the autoimmune repertoire present in MuS patients revealing novel oligodendroglial and/or neuronal putative autoantigens, with potential important pathogenic and diagnostic implications.